Document
type: Class

Academic Article
type: Class

Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
type: Document
type: Academic Article
type: Generically Dependent Continuant
type: Article
most specific type: Academic Article
type: Entity
type: Continuant
related by: 11010622
type: Thing
language: Inglese
type: Information Content Entity

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

Article
type: Class

individual
rights: termsOfUse
date: 2026-08-24T04:10:01
publisher: Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
type: Document
label: RDF description of Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects - http://irises.unilink.it/resource/item/49063

11010622
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects

Information Content Entity
type: Class

Inglese
type: Language